MORE VIDEOS
Explore more

Latest videos

How Does Histology Alter Treatment? Cora N. Sternberg, M.D., FACP
How Does Histology Alter Treatment? Cora N. Sternberg, M.D., FACP administrator 1 Views • 2 years ago

The world's largest, most respected, and fully accredited kidney cancer charity.
Robotic resection of Perigastric Metastasis from HLRCC
Robotic resection of Perigastric Metastasis from HLRCC administrator 3 Views • 2 years ago

Dr. Ball removes a metastatic deposit near the stomach.
What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond
What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond administrator 0 Views • 2 years ago

What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond presented by Mayer Fishman, MD PhD
Dept. of GU Oncology Moffitt Cancer Center Dept. of Oncologic Sciences, USF Morsani College of Medicine at the Kidney Cancer Association National Patient and Caregiver Conference – Chicago, IL September 22, 2018.
Intravenous Leiomyomatosis
Intravenous Leiomyomatosis administrator 0 Views • 2 years ago

A condition in which leiomyomata grow in veins from a fibroid, showing semi-metastatic behavior.
A Dummies Guide to Diagnosis of Renal Tumors Using Pattern-Based Approach
A Dummies Guide to Diagnosis of Renal Tumors Using Pattern-Based Approach administrator 0 Views • 2 years ago

The classification of renal tumors is becoming increasingly complex. Learn how you can use a simple pattern-based approach to classify the majority of renal tumors. This video features Dr. Rajal B. Shah, an expert genitourinary pathologist, educator, textbook author and author of many landmark papers on prostate and other urologic cancers.
Hereditary Renal Cancer Syndrome Prof Tarek El Diasty
Hereditary Renal Cancer Syndrome Prof Tarek El Diasty administrator 2 Views • 2 years ago

Systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
Systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma administrator 6 Views • 2 years ago

Systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma presented by Pavlos Msaouel, MD, PhD
Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center at the Kidney Cancer Association National Patient and Caregiver Conference – Chicago, IL September 22, 2018.
At the NIH Clinical Center: Steven Abboud works on cancer treatments
At the NIH Clinical Center: Steven Abboud works on cancer treatments administrator 2 Views • 2 years ago

Meet Steven Abboud, a research scholar at the Urologic Oncology Branch in the Center for Cancer Research at the NIH Clinical Center. Abboud's research involves trying to form treatments for muscle, kidney and prostate cancers using biology. Abboud is participating in the Medical Research Scholars Program coordinated by the NIH Clinical Center's Office of Clincal Research Training and Medical Education. Video courtesy of Lab TV https://www.labtv.com/Home#/. LabTV interview conducted in 2014.

Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma
Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma administrator 2 Views • 2 years ago

Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment

CME Available: https://auau.auanet.org/node/29362

Upon completion of this activity, participants will be able to:
1. State how to manage bleeding complications of robotic partial nephrectomy.
2. Describe the algorithm of Immunotherapy treatment of advanced Renal Cell Carcinoma.
3. Explain how to minimize positive margin rates of robotic partial nephrectomy.

This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck
Pfizer, Inc.
Sanofi Genzyme

CAP education session Kidney cancer Dr Trpkov 2018
CAP education session Kidney cancer Dr Trpkov 2018 administrator 3 Views • 2 years ago

View Dr. Kiril Trpkov’s College of American Pathologists (CAP) Cancer Protocols Education Session on kidney cancer from February 21, 2018. CAP Cancer Protocols Education Sessions are sponsored by the Canadian Partnership Against Cancer, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO).

For more information, see http://www.cancerview.ca/treat....mentandsupport/synop

Showing 3248 out of 3249